Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Profit After Tax: 2020-2025

Historic Profit After Tax for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -$27.5 million.

  • Caribou Biosciences' Profit After Tax rose 20.57% to -$27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.1 million, marking a year-over-year decrease of 6.09%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.08% down from last year.
  • Latest data reveals that Caribou Biosciences reported Profit After Tax of -$27.5 million as of Q3 2025, which was up 49.08% from -$54.1 million recorded in Q2 2025.
  • Caribou Biosciences' 5-year Profit After Tax high stood at -$10.0 million for Q3 2023, and its period low was -$54.1 million during Q2 2025.
  • For the 3-year period, Caribou Biosciences' Profit After Tax averaged around -$33.9 million, with its median value being -$34.7 million (2024).
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 664.48% in 2021, then skyrocketed by 62.46% in 2023.
  • Over the past 5 years, Caribou Biosciences' Profit After Tax (Quarterly) stood at -$18.5 million in 2021, then slumped by 46.05% to -$27.0 million in 2022, then declined by 27.85% to -$34.5 million in 2023, then declined by 2.85% to -$35.5 million in 2024, then increased by 20.57% to -$27.5 million in 2025.
  • Its Profit After Tax stands at -$27.5 million for Q3 2025, versus -$54.1 million for Q2 2025 and -$40.0 million for Q1 2025.